comparemela.com

Latest Breaking News On - Nasdaq accd - Page 14 : comparemela.com

Accolade (NASDAQ:ACCD) Coverage Initiated at Stephens

Investment analysts at Stephens initiated coverage on shares of Accolade (NASDAQ:ACCD – Get Rating) in a report released on Tuesday, The Fly reports. The brokerage set an “overweight” rating on the stock. ACCD has been the topic of a number of other research reports. Bank of America increased their target price on Accolade from $12.50 […]

Accolade, Inc (NASDAQ:ACCD) Receives Consensus Rating of Moderate Buy from Brokerages

Shares of Accolade, Inc. (NASDAQ:ACCD – Get Rating) have been given an average rating of “Moderate Buy” by the eighteen ratings firms that are currently covering the stock, MarketBeat Ratings reports. Seven research analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 1-year […]

Jounce Therapeutics (NASDAQ:JNCE) Coverage Initiated at StockNews com

Accolade (NASDAQ:ACCD – Get Rating) had its price target boosted by Bank of America from $12.50 to $14.50 in a research note published on Tuesday, The Fly reports. They currently have a neutral rating on the stock. Several other research firms have also commented on ACCD. Guggenheim upgraded shares of Accolade from a neutral rating […]

Accolade (NASDAQ:ACCD) Upgraded to Buy by Guggenheim

Guggenheim upgraded shares of Accolade (NASDAQ:ACCD – Get Rating) from a neutral rating to a buy rating in a report released on Thursday, MarketBeat reports. The brokerage currently has $16.00 price target on the stock. Other research analysts have also issued research reports about the company. Raymond James started coverage on Accolade in a report […]

Accolade (NASDAQ:ACCD) Raised to Buy at Guggenheim

Guggenheim upgraded shares of Accolade (NASDAQ:ACCD – Get Rating) from a neutral rating to a buy rating in a research note released on Thursday morning, MarketBeat reports. Guggenheim currently has $16.00 target price on the stock. Several other brokerages also recently issued reports on ACCD. Truist Financial raised their target price on shares of Accolade […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.